Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Gilead Sciences: How Good Will Earnings Be?
Barron's
Wednesday, July 16, 2014 - 10:35am
tags:
Gilead Sciences, earnings
Pfizer says clotting drug's once-weekly dose reduces bleeding rate
Yahoo/Reuters
Wednesday, July 16, 2014 - 10:20am
tags:
Pfizer, BeneFix, hemophilia B
Pfizer: Struggling Through A Tough Time
Seeking Alpha
Wednesday, July 16, 2014 - 8:58am
tags:
Pfizer, China, Viagra, patents, Cellectis, oncology
St Jude Medical's quarterly profit doubles as expenses fall
Yahoo/Reuters
Wednesday, July 16, 2014 - 8:49am
tags:
earnings, devices, St. Jude Medical
Abbott Labs shares climb 2.7% as profit, sales top estimates
Marketwatch
Wednesday, July 16, 2014 - 8:47am
tags:
earnings, Abbott Labs
St. Jude pays $200 million for chronic pain device maker NeuroTherm
Yahoo/Zacks.com
Tuesday, July 15, 2014 - 2:06pm
tags:
St. Jude Medical, M&A, devices, chronic pain, NeuroTherm
Questcor's Own Data Blatantly Shows A 31% Decline In Net Sales Of Acthar By Aetna, With Other Insurers Following Suit - Mallinckrodt Shareholders, Pay Attention
Seeking Alpha
Tuesday, July 15, 2014 - 2:02pm
tags:
Questcor, Acthar, Mallinckrodt
Lilly Offers ‘Misleading’ Facts in our Patent Dispute, Says Canada
WSJ Online
Tuesday, July 15, 2014 - 11:49am
tags:
Eli Lilly, patents, Canada, Strattera, Zyprexa
[video] Turnaround: What Was Fixed at Johnson & Johnson?
Bloomberg
Tuesday, July 15, 2014 - 11:45am
tags:
JNJ
FTC Urged to Probe Shire, Sanofi & Icahn Med School Over A ‘Conspiracy’
WSJ Online
Tuesday, July 15, 2014 - 10:01am
tags:
FTC, Shire, Sanofi
Tax Reform, Not Tax Inversions, Will Rescue The U.S. Pharma, Bio, And Medical-Device Industries
Forbes
Tuesday, July 15, 2014 - 9:55am
tags:
tax reform, taxes, tax inversions, pharma industry, devices
Bank Of America Boosts AbbVie Price Target On Increased Likelihood Of Deal
Yahoo/Benzinga
Tuesday, July 15, 2014 - 9:49am
tags:
AbbVie, Shire, M&A
The next hepatitis C? NASH
CNBC
Tuesday, July 15, 2014 - 9:48am
tags:
NASH, hepatitis C, liver disease, nonalcoholic steatohepatitis, Genfit, Gilead Sciences, Intercept Pharma
Eli Lilly announces results from five datasets from Alzheimer's disease study
The Fly on the Wall
Tuesday, July 15, 2014 - 9:46am
tags:
Eli Lilly, Alzheimer's disease
Google Smart Contact Lens Focuses On Healthcare Billions
Forbes
Tuesday, July 15, 2014 - 9:41am
tags:
Novartis, Google, smart contact lens, Alcon
J&J 2Q profit climbs 13 percent on new-drug sales
Yahoo/AP
Tuesday, July 15, 2014 - 9:37am
tags:
JNJ, earnings
Shire Warm To AbbVie's Latest, Sweeter $54B Offer
Forbes
Monday, July 14, 2014 - 7:04pm
tags:
Shire, AbbVie, M&A
Medtronic Not Sticking Around To Rearrange Chairs On The Titanic
Seeking Alpha
Monday, July 14, 2014 - 7:02pm
tags:
Medtronic, devices, Covidien
1 Hidden Blockbuster Lurking in Merck's Pipeline?
Motley Fool
Monday, July 14, 2014 - 7:01pm
tags:
Merck, Doravirine, MK-1439, HIV, Isentress
Targacept stops Alzheimer's drug trial after it fails mid-stage
Yahoo/Reuters
Monday, July 14, 2014 - 6:59pm
tags:
Targacept, Alzheimer's disease, TC-1734

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.